Last Thursday, the FDA gave full approval to the first drug intended to treat COVID-19, but a recent Vox article suggests they may have put the cart ahead of the horse. Remdesivir is an antiviral drug developed by Gilead Sciences, and is marketed under the brand Veklury. It had previously received emergency use authorization back in May for severe COVID cases, and was allowed to be used on less serious cases when the FDA relaxed its guidelines in August.
Should the FDA Have Approved Remdesivir?
Researchers question the validity of the FDA’s first approved COVID-19 drug.
Oct 30, 2020
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
